Spanish 
Chinese 
Russian 
German 
French 
Japanese 
Portuguese 
Hindi Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.
Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers
Useful Links
Share This Page
Anthrax toxin
Anthrax toxin is a three-protein exotoxin secreted by virulent strains of the bacterium, bacillus anthracis-the causative agent of anthrax. The toxin was first discovered by Harry Smith in 1954. Anthrax toxin is composed of a cell-binding protein, known as protective antigen (PA), and two enzyme components, called Edema factor (EF) and Lethal factor (LF). These three protein components act together to impart their physiological effects. Anthrax is a disease caused by bacillus anthracis, a spore-forming, gram positive, rod-shaped bacterium. The lethality of the disease is caused by the bacterium's two principal virulence factors: (i) the polyglutamic acid capsule, which is anti-phagocytic, and (ii) the tripartite protein toxin, called anthrax toxin. Anthrax toxin is a mixture of three protein components: (i) protective antigen (PA), (ii) edema factor (EF), and (iii) lethal factor (LF). Toxic symptoms are not observed when these proteins are injected individually into laboratory animals.
Related Journals: Journal of Critical reviews in Microbiology, Research Journal of Toxins, International Journal of Current Toxins Research.
Anthrax toxin
Expert PPTs
- Hosam A Elbaz
Characterization of the pharmacological effects of cardiac glycosides on lung epithelial cells
PPT Version | PDF Version
Speaker PPTs
- Jalil Mehrzd
Bioluminescence-based detection of brain immune cells apoptosis and ATP depletion induced by aflatoxin B1
PPT Version | PDF Version - Ben Nelson
Purity, endotoxin level, and trace metal comparison of different grades of trehalose
PPT Version | PDF Version - Ivan U. Kouzel
Glycosphingolipid-mediated interaction of Shiga toxin with the human endothelium: status quo of receptor research
PPT Version | PDF Version - Xingmin Sun
A chimeric protein (mTcd138) comprising the glucosyltransferase and domains of toxin B and the receptor binding domain of toxin A provides full protection against Clostridium difficile infection in mice
PPT Version | PDF Version - Ming-Hsien Wang
Cytotoxic Necrotizing Factor-1 Toxin in Uropathogenic E. coli: Is There a Role for Virulence Factors in Urinary Tract Infection?
PPT Version | PDF Version - Dominique Batifol
Intra-articular injection of Botulinum toxin analgesic effect
PPT Version | PDF Version - Carlos Corassin
Efficiency of different sources of Saccharomyces cerevisiae for decontamination of aflatoxin B1 in phosphate buffer saline solution
PPT Version | PDF Version - Gaylen Uhlich
Production and regulation of functional amyloid curli fimbriae by Shiga toxin-producing Escherichia coli.
PPT Version | PDF Version